Understanding the population characteristics of neurodevelopmental disorders is an important way to find modifiable risk factors and help determine needed services.
Neurodevelopmental disorders have been linked to poor social and health outcomes. An understanding of population data on age at time of diagnosis, demographic variations, and incidence are incredibly helpful in the identification of risk factors that are modifiable and can impact the planning of services and intervention. A new population-based cohort investigation offers some of this key information.1
Investigators used nationwide data using birth cohorts from the 2000-2014 Medicaid Analytic eXtract and the 2003-2015 IBM MarketScan Research Database to find children who were publicly and privately insured at the time of their birth. Identified conditions included attention-deficit/hyperactivity disorder, learning disabilities, speech or language disorders, developmental coordination disorders, intellectual disabilities, neurodevelopmental disorders, autism spectrum disorders, and behavioral disorders. Analyses estimated the incidence and timing of diagnosis, which was stratified by child’s sex, birth year, maternal age at delivery, and race and ethnicity.
The sample included 2,070,541 children who were publicly insured and 1,309,900 children insured privately at the time of birth. By their 8th birth, 23.9% of publicly insured children and 11.0% of privately insured children had been given a diagnosis of at least 1 neurodevelopmental disorder:
The risk of diagnosis was found to be much higher among boys (incidence of ≥1 neurodevelopmental disorder by age 8 years for boys vs girls: 30.7% vs 16.7% among publicly insured children and 15.0% vs 6.7% among privately insured children) and White children (30.2% vs 9.1% among Asian children, 23.0% among Black children, 15.4% among Hispanic children, and 22.7% among children of unknown race or ethnicity; information on race and ethnicity was available only for publicly insured children). With the exception of attention-deficit/hyperactivity disorder, diagnosis occurred slightly earlier for children with private insurance. Co-occurring disorders were common, particularly in children who had intellectual disability and autism spectrum disorder (>70% had ≥1 other disorder).
The investigators concluded that there was a fairly high incidence of and co-occurrence of neurodevelopmental disorders, but a disparity in incidence and timing of diagnosis by insurance type and race and ethnicity existed. They believe the results show the importance of timely, accessible developmental assessments and educational services.
Reference
1. Straub L, Bateman B, Hernandez-Diaz S, et al. Neurodevelopmental disorders among publicly or privately insured children in the United States. JAMA Psychiatry. Epub ahead of print. January 5, 2022. doi:10.1001/jamapsychiatry.2021.3815
Paternal depression associated with adverse childhood experiences in children
October 21st 2023In this Q&A, Kristine H. Schmitz, MD, explains her team's recent research on paternal depression and adverse childhood experiences during the 2023 American Academy of Pediatrics National Conference & Exhibition.
Exome sequencing should be used for diagnosing cerebral palsy
October 13th 2023A systematic review and meta-analysis found that such sequencing indeed has an equivalent high genetic diagnostic yield in cerebral palsy, which supports including this neurodevelopmental disorder among those for which diagnostic exome sequencing should be used.
Is ADHD associated with shorter-than-expected height?
October 10th 2023To assess the role of familial factors, investigators analyzed data for a family-based group created from another Swedish national register that included 833,172 individuals without ADHD with different levels of relatedness to the individuals with ADHD and a group of matched controls.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.